This theory-focused article unpacks J. Craig Venter’s synthetic genomics research and his TED talk framework, explaining the DBTL workflow used to build minimal synthetic bacterial cells, distinguishing them from GMOs and outlining their climate, pharmaceutical and ethical regulatory implications.

